464280 — TDSPharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for TDSPharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8,122	9,937	15,136	30,704
Net Total Accounts Receivable
Net Total Receivables	3,014	5,699	6,806	5,743
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	13,134	17,950	24,480	39,640
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10,207	9,705	8,917	8,881
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	26,967	30,469	33,970	49,161
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9,585	9,830	10,065	10,517
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	10,824	12,160	11,025	10,656
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	16,143	18,308	22,945	38,504
Total Liabilities & Shareholders' Equity	26,967	30,469	33,970	49,161
Total Common Shares Outstanding